MoneyWorks4Me

Lyka Labs - Quaterly Results

02 Aug 2023 Evaluate
Revenue reduced marginally to stand at Rs. 212.37 millions during the quarter ended June 2023. The figure stood at Rs. 218.78 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -17.20 millions as compared to Net Profit of Rs. 3.27 millions of corresponding quarter ended June 2022Operating profit for the quarter ended June 2023 decreased to 29.85 millions as compared to 66.04 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 212.37 218.78 -2.93 212.37 218.78 -2.93 805.93 1643.49 -50.96
Other Income 4.28 6.84 -37.43 4.28 6.84 -37.43 34.52 27.20 26.91
PBIDT 29.85 66.04 -54.80 29.85 66.04 -54.80 190.52 1002.19 -80.99
Interest 13.33 28.01 -52.41 13.33 28.01 -52.41 115.70 199.21 -41.92
PBDT 16.52 38.02 -56.55 16.52 38.02 -56.55 3.08 756.30 -99.59
Depreciation 33.35 34.14 -2.31 33.35 34.14 -2.31 135.16 153.89 -12.17
PBT -16.83 3.88 -533.76 -16.83 3.88 -533.76 -132.08 602.41 -121.93
TAX 0.37 0.61 -39.34 0.37 0.61 -39.34 0.78 203.38 -99.62
Deferred Tax -1.98 0.61 -424.59 -1.98 0.61 -424.59 -1.29 203.38 -100.63
PAT -17.20 3.27 -625.99 -17.20 3.27 -625.99 -132.86 399.03 -133.30
Equity 330.90 286.90 15.34 330.90 286.90 15.34 306.90 286.90 6.97
PBIDTM(%) 14.06 30.19 -53.44 14.06 30.19 -53.44 23.64 60.98 -61.23
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..